TCI Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

TCI Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-86	Closed	-$2.54K	–	2619
2022 Q4	$2.54K	Buy	+86	New	+$3.09K	﹤0.01%	1917
2022 Q3	–	Sell	-106	Closed	-$3K	–	2541
2022 Q2	$3K	Buy	+106	New	+$2.68K	﹤0.01%	1885
2022 Q1	–	Sell	-81	Closed	-$4K	–	2427
2021 Q4	$4K	Buy	81 +13	+19%	+$682	﹤0.01%	1890
2021 Q3	$4K	Buy	68 +9	+15%	+$751	﹤0.01%	1815
2021 Q2	$5K	Buy	59 +22	+59%	+$1.18K	﹤0.01%	1479
2021 Q1	$2K	Buy	+37	New	+$1.46K	﹤0.01%	1876

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TCI Wealth Advisors's FLNA Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Filana Therapeutics (FLNA) in Q1 2023, closing a stake of 86 shares — an estimated $2.54K sold.

TCI Wealth Advisors first reported a position in FLNA in Q1 2021 and held it in 6 quarters. The position peaked at $5K in Q2 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q1 2023.

TCI Wealth Advisors reported no remaining Filana Therapeutics position as of Q1 2023 after selling out during the quarter.
TCI Wealth Advisors sold 86 Filana Therapeutics shares in Q1 2023, an estimated $2.54K.
TCI Wealth Advisors first reported a position in Filana Therapeutics in Q1 2021 and held it in 6 quarters.
TCI Wealth Advisors's Filana Therapeutics position peaked at $5K in Q2 2021.
145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.